Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763992011 | Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3763993018 | Lamivudine 60 mg and nevirapine 100 mg and stavudine 12 mg orodispersible tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing lamivudine and nevirapine and stavudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has active ingredient | Stavudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has active ingredient | Lamivudine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has active ingredient | Nevirapine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Dispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Dispersible tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has manufactured dose form | Conventional release orodispersible tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing only lamivudine and nevirapine and stavudine in oromucosal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 12 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance | Lamivudine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Lamivudine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Stavudine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance | Nevirapine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 100 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has presentation strength numerator value | 60 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has basis of strength substance | Stavudine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Has precise active ingredient | Nevirapine | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Plays role | Antiretroviral therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely lamivudine 60 milligram and nevirapine 100 milligram and stavudine 12 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | Product containing only lamivudine and nevirapine and stavudine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR